Cargando…

Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis

Feline infectious peritonitis (FIP) is a complex and historically fatal disease, though recent advances in antiviral therapy have uncovered potential treatments. A newer therapeutic option, unlicensed molnupiravir, is being used as a first-line therapy for suspect FIP and as a rescue therapy to trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Meagan, Jacque, Nicole, Novicoff, Wendy, Li, Emma, Negash, Rosa, Evans, Samantha J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612227/
https://www.ncbi.nlm.nih.gov/pubmed/36297266
http://dx.doi.org/10.3390/pathogens11101209
_version_ 1784819722232004608
author Roy, Meagan
Jacque, Nicole
Novicoff, Wendy
Li, Emma
Negash, Rosa
Evans, Samantha J. M.
author_facet Roy, Meagan
Jacque, Nicole
Novicoff, Wendy
Li, Emma
Negash, Rosa
Evans, Samantha J. M.
author_sort Roy, Meagan
collection PubMed
description Feline infectious peritonitis (FIP) is a complex and historically fatal disease, though recent advances in antiviral therapy have uncovered potential treatments. A newer therapeutic option, unlicensed molnupiravir, is being used as a first-line therapy for suspect FIP and as a rescue therapy to treat cats who have persistent or relapsed clinical signs of FIP after GS-441524 and/or GC376 therapy. Using owner-reported data, treatment protocols for 30 cats were documented. The 26 cats treated with unlicensed molnupiravir as a rescue therapy were treated with an average starting dosage of 12.8 mg/kg and an average ending dosage of 14.7 mg/kg twice daily for a median of 12 weeks (IQR = 10–15). In total, 24 of 26 cats were still living disease-free at the time of writing. One cat was euthanized after completing treatment due to a prolonged seizure, and the other cat underwent retreatment for relapsed clinical signs. Few adverse effects were reported, with the most notable—folded ears (1), broken whiskers (1), and severe leukopenia (1)—seen at dosages above 23 mg/kg twice daily. This study provides a proof of principle for the use of molnupiravir in cats and supports the need for future studies to further evaluate molnupiravir as a potentially safe and effective therapy for FIP.
format Online
Article
Text
id pubmed-9612227
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96122272022-10-28 Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis Roy, Meagan Jacque, Nicole Novicoff, Wendy Li, Emma Negash, Rosa Evans, Samantha J. M. Pathogens Article Feline infectious peritonitis (FIP) is a complex and historically fatal disease, though recent advances in antiviral therapy have uncovered potential treatments. A newer therapeutic option, unlicensed molnupiravir, is being used as a first-line therapy for suspect FIP and as a rescue therapy to treat cats who have persistent or relapsed clinical signs of FIP after GS-441524 and/or GC376 therapy. Using owner-reported data, treatment protocols for 30 cats were documented. The 26 cats treated with unlicensed molnupiravir as a rescue therapy were treated with an average starting dosage of 12.8 mg/kg and an average ending dosage of 14.7 mg/kg twice daily for a median of 12 weeks (IQR = 10–15). In total, 24 of 26 cats were still living disease-free at the time of writing. One cat was euthanized after completing treatment due to a prolonged seizure, and the other cat underwent retreatment for relapsed clinical signs. Few adverse effects were reported, with the most notable—folded ears (1), broken whiskers (1), and severe leukopenia (1)—seen at dosages above 23 mg/kg twice daily. This study provides a proof of principle for the use of molnupiravir in cats and supports the need for future studies to further evaluate molnupiravir as a potentially safe and effective therapy for FIP. MDPI 2022-10-20 /pmc/articles/PMC9612227/ /pubmed/36297266 http://dx.doi.org/10.3390/pathogens11101209 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Roy, Meagan
Jacque, Nicole
Novicoff, Wendy
Li, Emma
Negash, Rosa
Evans, Samantha J. M.
Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis
title Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis
title_full Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis
title_fullStr Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis
title_full_unstemmed Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis
title_short Unlicensed Molnupiravir is an Effective Rescue Treatment Following Failure of Unlicensed GS-441524-like Therapy for Cats with Suspected Feline Infectious Peritonitis
title_sort unlicensed molnupiravir is an effective rescue treatment following failure of unlicensed gs-441524-like therapy for cats with suspected feline infectious peritonitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612227/
https://www.ncbi.nlm.nih.gov/pubmed/36297266
http://dx.doi.org/10.3390/pathogens11101209
work_keys_str_mv AT roymeagan unlicensedmolnupiravirisaneffectiverescuetreatmentfollowingfailureofunlicensedgs441524liketherapyforcatswithsuspectedfelineinfectiousperitonitis
AT jacquenicole unlicensedmolnupiravirisaneffectiverescuetreatmentfollowingfailureofunlicensedgs441524liketherapyforcatswithsuspectedfelineinfectiousperitonitis
AT novicoffwendy unlicensedmolnupiravirisaneffectiverescuetreatmentfollowingfailureofunlicensedgs441524liketherapyforcatswithsuspectedfelineinfectiousperitonitis
AT liemma unlicensedmolnupiravirisaneffectiverescuetreatmentfollowingfailureofunlicensedgs441524liketherapyforcatswithsuspectedfelineinfectiousperitonitis
AT negashrosa unlicensedmolnupiravirisaneffectiverescuetreatmentfollowingfailureofunlicensedgs441524liketherapyforcatswithsuspectedfelineinfectiousperitonitis
AT evanssamanthajm unlicensedmolnupiravirisaneffectiverescuetreatmentfollowingfailureofunlicensedgs441524liketherapyforcatswithsuspectedfelineinfectiousperitonitis